MCNAMARA KEVIN J 4

What Happened Kevin J. McNamara, President, CEO and a director of Chemed Corp., sold 2,000 shares in open-market transactions on March 12, 2026. The weighted-average price reported was $403.18 per share, producing gross proceeds of approximately $806,360. The filing notes the shares were sold in multiple trades at prices ranging from $399.31 to $404.68.

Key Details

• Transaction date: 2026-03-12; Form 4 filed: 2026-03-13.
• Transaction type: Open-market sale (Code S).
• Price: Weighted average $403.18; range $399.31–$404.68 (per footnote).
• Proceeds: ~ $806,360.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 states the reported price is a weighted average and the reporter will provide a breakdown of the individual trade prices/quantities on request.
• Timeliness: Filed the next day; appears timely (Form 4s are generally due within two business days).

Context This was an outright sale (disposition) by the CEO in the open market. Sales by executives can be routine (tax planning, diversification, liquidity) and do not by themselves indicate company performance or management views. For more granular detail (exact number of shares sold at each price or post-sale holdings), request the breakdown noted in the footnote or consult the full SEC filing.